To support continuous learning, DIA brings you complimentary digital downloads to spur thought, reflection, collaboration, and action. In your Resource Kit, you'll find links to intriguing articles from the DIA Global Forum and our peer-reviewed journal, Therapeutic Innovation & Regulatory Science (TIRS), exclusive podcast interviews, session recordings from DIA events, and more!
- Optimize Additional Risk Minimization Measures with End-to-End Drug Labeling
- A Career in Pharmacovigilance: Automation with a Human Touch
- Ensuring Data Privacy in EU Pharmacovigilance
- Pharmacovigilance: Artificial Intelligence and Global Regulatory Changes During the Pandemic
- Pharmacovigilance Systems in Latin America for COVID-19 Vaccines: Brazil, Chile, Costa Rica, and Mexico
- Implementing New GVP in China Requires Digitization and Training
- Special Section: Pharmacovigilance: Artificial Intelligence Can Save Pharmacovigilance in Australia
- Special Section: Pharmacovigilance: Emerging Pharmacovigilance Framework Ensuring Safe COVID-19 -Vaccines in China
- Special Section: Pharmacovigilance: Positioning Pharmacovigilance During the Pandemic in Japan
- Special Section: Pharmacovigilance: How Valuable is Patient Direct Reporting in Pharmacovigilance?
- Special Section: Pharmacovigilance: Smart Safety Surveillance (3S): A Proven Approach to Building Functional LMIC Pharmacovigilance Systems
- Special Section: Pharmacovigilance: Three Good Reasons to Use Artificial Intelligence in Pharmacovigilance
- Special Section: Pharmacovigilance: Advanced Analytics Drives Innovation in Pharmacovigilance Risk Management Systems
- Special Section: Pharmacovigilance: Using Community Reporters as a Strategic Source for Evaluating Vaccine Effectiveness
- Special Section: Pharmacovigilance: Monitoring Safety Signals for Vaccines: Current Strategies and Future Directions
- Special Section: Pharmacovigilance: Six Key Considerations to Scale Pharmacovigilance with Modern Technologies
Download Kit